Lipoprotein biosynthetic process

pathway activity — cross-omics
GO:0042158Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Lipoprotein biosynthetic process pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are RPL5, RPL6, and RPL18A_S123, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Lipoprotein biosynthetic process activity versus RPL5 in GBM (Pearson r = -0.48).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMRPL5 →-0.242-0.049<.001<.00137
GBMRPL6 →-0.521-0.047.001.00137
HNSCRPL18A_S123 →-0.268-0.040.001.00237
PDACSLC39A14 →-0.359-0.020.001.00936
GBMHYI →+0.363+0.045<.001<.00136
BRCASEC24A →-0.239-0.025<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0042158 vs RPL5 — GBM

Per-sample scatter of Lipoprotein biosynthetic process activity vs RPL5 in GBM.

Explore this scatter interactively →

Exploration